[1]
J. H. H. Alsaadi, “Interferon-Beta-1a (Rebif) a Risk Factor on Liver, Kidney and Sex Hormones with Multiple Sclerosis Patients: A Review”, AJBP, vol. 2, no. 4, pp. 1–13, Apr. 2025.